Cidara Therapeutics | 8-K:重大事件
Cidara Therapeutics | 4:持股变动声明-高管 Sandison Taylor
Cidara Therapeutics | 4:持股变动声明-高管 Tari Leslie
Cidara Therapeutics | 8-K:重大事件
Cidara Therapeutics | S-8:员工福利计划证券登记
Cidara Therapeutics | 8-K:Cidara Therapeutics提供公司最新情况并报告2024年第二季度财务业绩
Cidara Therapeutics | 10-Q:2024财年二季报
Cidara Therapeutics | EFFECT:其他
Cidara Therapeutics | 424B3:募资说明书
Cidara Therapeutics | SC 13G:超过5%持股股东披露文件-BCLS Fund III Investments, LP(9.99%)
Cidara Therapeutics | SC 13G:超过5%持股股东披露文件-Canaan XII L.P.(9.99%),Canaan Partners XII LLC(9.99%)
Cidara Therapeutics | CORRESP:信函
Cidara Therapeutics | UPLOAD:其他
Cidara Therapeutics | SC 13D:超过5%持股股东披露文件-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
Cidara Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4/A:持股变动声明(修正)-董事 RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Cidara Therapeutics | 4:持股变动声明-董事 BURGESS DANIEL D
Cidara Therapeutics | 4:持股变动声明-董事 Bassler Bonnie L
Cidara Therapeutics | S-1:证券上市注册声明
暂无数据
暂无数据